key: cord-0711478-cdly66jw
authors: Devresse, Arnaud; Albichr, Imane Saad; Georgery, Hélène; Yombi, Jean Cyr; De Greef, Julien; Belkhir, Leila; Mzougui, Samy; Scohy, Anais; Darius, Tom; Buemi, Antoine; Goffin, Eric; Kabamba, Benoit; Kanaan, Nada
title: T-cell and Antibody Response After 2 Doses of the BNT162b2 Vaccine in a Belgian Cohort of Kidney Transplant Recipients
date: 2021-07-08
journal: Transplantation
DOI: 10.1097/tp.0000000000003892
sha: 4fb75518730f23eee6b7161ae4ec94382ebd5463
doc_id: 711478
cord_uid: cdly66jw

nan

D isappointing results in the humoral response after anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in kidney transplant recipients (KTRs) have emerged from the literature. 1, 2 In this context, exploring SARS-CoV-2-specific cellular response induced by vaccination is relevant.

We prospectively assessed the antibody (Ab) (with an immunoassay detecting Ab against the spike protein receptor-binding domain [RBD] [Elecsys anti-SARS-CoV-2, Roche Diagnostics GmbH, Mannheim, Germany-positive threshold >0.8 U/mL and upper limit of detection 250 U/mL]) and T-cell response (with a whole blood interferon-gamma [IFN-γ] release assay [IGRA] using the antigens of the SARS-CoV-2 spike protein to activate T cells, following manufacturer's instructions [SARS-CoV-2 IGRA, Euroimmun, Lübeck, Germany-positive threshold >100 mIU/mL]) rates 1 mo after the second dose of the mRNA BNT162b2 vaccine (Pfizer-BioNTech), between April 17, 2021 and June 15, 2021, in a single-center cohort of KTRs. All patients signed informed consent and the study received institutional review board approval (B4032021000056 The cellular response rate and IFN-γ values were not significantly different between Ab responders and Ab nonresponders ( Figure 1A) . However, KTRs displaying high Ab response (anti-RBD Ab titer >150 U/mL) had significantly higher cellular response rate and IFN-γ values compared with KTRs with a weaker-or no-Ab response ( Figure 1A and B). Correlation between IFN-γ and Ab values ( Figure 1C ) was statistically significant (r = 0.666, P < 0.001, Pearson correlation test).

Reports on the T-cell response rate after anti-SARS-CoV-2 vaccination in KTRs are limited. Bertrand et al 3 found a 57.8% T-cell response rate in 26 KTRs after 2 doses of the BNT162b2 vaccine, using an ELISpot immunoassay. Cucchiari et al 4 reported a 54.7% rate after the second dose of the mRNA-1273 vaccine in 117 SARS-CoV-2 naive transplant patients, also using an ELISpot immunoassay. We found a lower rate (32%) that might be explained by the differences in sensitivity of the ELISpot test compared with IGRA ELISA as reported for the detection of latent tuberculosis infection. 5 Interestingly, we found that 20% of Ab nonresponders have a T-cell response and 72% of KTRs showed either IFN-γ or Ab response. Moreover, KTRs with higher Ab response are more likely to develop a T-cell response. In that context, a third vaccine dose might help boost both cellular and serological responses. Larger studies are needed to characterize the cellular response and its clinical relevance.

Disappointing immunization rate after two doses of the BNT162b2 vaccine in a Belgian cohort of kidney transplant recipients. Transplantation. [Epub ahead of print

Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients

Antibody and T cell response to SARS-CoV-2 messenger RNA BNT162b2 vaccine in kidney transplant recipients and hemodialysis patients

Cellular and humoral response after mRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients

Advances in the diagnosis of tuberculosis

The cellular response rate was not significantly different between patients with antibody response and without antibody response (P = 0.138, χ 2 test). However, among patients with humoral response, those with high antibody response (anti-RBD titers >150 U/mL) showed higher rates of cellular response compared with others

Patients with antibody titers >150 U/mL had higher IFN-γ values than others (P = 0.049, Kruskal-Wallis test). C, Correlation between anti-RBD antibody titers and IFN-γ values

IFN-γ, interferon-gamma

RBD, receptor-binding domain

Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited